Another possible role for MMP-9 arises from the observation that MMP-9 produced by cancer cells cleaves CD25 expressed on the surface of tumor-infiltrating T cells and reduces their proliferation in vitro20, suggesting that a similar mechanism may downregulate T cell activation in vivo by limiting T cell reactivity to IL-2. The gene discussed is MMP9; the disease is cancer.